alpha2-antiplasmin replacement therapy (Bayer)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namealpha2-antiplasmin replacement therapy (Bayer)
Drug Alias Namealpha2-AP replacement therapy (Bayer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasminogen inhibitors
TargetsPlasminogen
Therapy Area/IndicationsHemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer Corp
Active IndicationsN/A
Inactive IndicationsHemorrhage

Other Information

ATC CodeN/A
Related LinksN/A